cDC1 prime and are licensed by CD4 T cells to induce anti-tumour immunity

Conventional type 1 dendritic cells (cDC1s(1)) are thought to perform antigen cross-presentation required to prime CD8 T cells(2,3), while cDC2 are considered specialized for priming CD4 T cells(4,5). CD4 T cells are also thought to help CD8 T cell responses through a variety of mechanisms(6–11), in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferris, Stephen T., Durai, Vivek, Wu, Renee, Theisen, Derek J., Ward, Jeffrey P., Bern, Michael D., Davidson, Jesse T., Bagadia, Prachi, Liu, Tiantian, Briseño, Carlos G., Li, Lijin, Gillanders, William E., Wu, Gregory F., Yokoyama, Wayne M., Murphy, Theresa L., Schreiber, Robert D., Murphy, Kenneth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469755/
https://www.ncbi.nlm.nih.gov/pubmed/32788723
http://dx.doi.org/10.1038/s41586-020-2611-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469755/
https://www.ncbi.nlm.nih.gov/pubmed/32788723
http://dx.doi.org/10.1038/s41586-020-2611-3

Ejemplares similares